Home Newsfeeds AIM ImmunoTech Q3 EPS $(0.13) Down From $(0.08) YoY

AIM ImmunoTech Q3 EPS $(0.13) Down From $(0.08) YoY

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.13) per share. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year.

byBenzinga Newsdesk

November 15, 2022

1 minute read

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.13) per share. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year.

Integra LifeSciences Expects Q2 Revenue of $411M-$416M Vs $395.8M Est, Adj EPS of $0.60-$0.65 Vs $0.75 Est

By Benzinga Newsdesk

May 6, 6:03 AM

2024 Outlook For the full year 2024, the Company is updating its revenue and adjusted EPS expectations to $1.672 to $1.687 billion and $3.01 to $3.11, respectively. The revenue

IART

Dow Surges Over 100 Points; World Acceptance Shares Spike Higher

By Lisa Levin

January 26, 3:45 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Thursday. The Dow traded up 0.35% to 33,863.38 while the NASDAQ rose 1.33% to 11,463.77. The S&P 500 also rose, gaining, 0.75% to 4,046.34.

ARDS